Recently adopting Apple’s Health Records to provide care which is increasingly patient centered and connected, the Cleveland Clinic have now partnered with Luye Medical Group in a new value-based collaboration.
As part of its ‘Healthy China 2030’ vision to establish a cluster of specialty groups, Luye Medical Group aims to bring exceptional healthcare services to Shanghai New Hong Qiao International Medical Center, with a focus on overall wellness, quality of care, and preventive screenings.
The collaboration will also introduce specialties, such as cardiology, urology, and oncology.
Headquartered in Singapore, Luye Medical oversees over 50 private healthcare organisations, from China, Australia and Singapore, to South Korea and New Zealand. In China, the organisation has established specialty areas and integrated services in Shanghai, Yantai, Chongqing and Chengdu.
A member of the Cleveland Clinic’s Connected international programme, which enables patients around the world to connect with its best practices and leading-edge technology, hospitals are able to deliver exceptional health services.
Through the programme, patients located in Shanghai will also gain access to detailed health education materials prepared by experts at Cleveland Clinic regarding various conditions and treatments on offer.
“With strong government support, Shanghai New Hong Qiao International Medical Center is positioned to be the pilot zone for national and Shanghai medical reform,” said Jie Yang, Chairman of Shanghai New Hong Qiao International Medical Center Construction Development Co. Ltd.
The collaboration between Luye Medical and Cleveland Clinic is expected to pave the way in developing a premium innovation healthcare hub and a high-end medical service platform based in Shanghai that can extend to the Yangtze River Delta, and service the whole country.”
“With our shared vision, we will strive for delivering world-class healthcare innovation and expertise to have a profound impact on the well-being of local community,” added Liu Dianbo, Chairman of the Board and President of Luye Life Sciences Group.
“As the collaboration advances, we look forward to working closely with public hospitals and universities to drive innovation with ‘hospital of the future’ collaboration centers and deliver international-level clinical outcomes and value to patients locally and nationally.”